505 related articles for article (PubMed ID: 30291376)
1. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
[TBL] [Abstract][Full Text] [Related]
2. Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.
Moore AR; Pienkos SM; Sinha P; Guan J; O'Kane CM; Levitt JE; Wilson JG; Shankar-Hari M; Matthay MA; Calfee CS; Baron RM; McAuley DF; Rogers AJ
Crit Care Med; 2023 Dec; 51(12):e269-e274. PubMed ID: 37695136
[TBL] [Abstract][Full Text] [Related]
3. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.
Dinglas VD; Hopkins RO; Wozniak AW; Hough CL; Morris PE; Jackson JC; Mendez-Tellez PA; Bienvenu OJ; Ely EW; Colantuoni E; Needham DM
Thorax; 2016 May; 71(5):401-10. PubMed ID: 26936876
[TBL] [Abstract][Full Text] [Related]
4. Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials.
Pienkos SM; Moore AR; Guan J; Levitt JE; Matthay MA; Baron RM; Conlon J; McAuley DF; O'Kane CM; Rogers AJ
Crit Care; 2023 Mar; 27(1):126. PubMed ID: 36978134
[TBL] [Abstract][Full Text] [Related]
5. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Calfee CS; Delucchi KL; Sinha P; Matthay MA; Hackett J; Shankar-Hari M; McDowell C; Laffey JG; O'Kane CM; McAuley DF;
Lancet Respir Med; 2018 Sep; 6(9):691-698. PubMed ID: 30078618
[TBL] [Abstract][Full Text] [Related]
6. Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study.
Sinha P; Delucchi KL; Chen Y; Zhuo H; Abbott J; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Calfee CS
Thorax; 2022 Jan; 77(1):13-21. PubMed ID: 34253679
[TBL] [Abstract][Full Text] [Related]
7. Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial.
Hashem MD; Hopkins RO; Colantuoni E; Dinglas VD; Sinha P; Aronson Friedman L; Morris PE; Jackson JC; Hough CL; Calfee CS; Needham DM
Thorax; 2022 Jan; 77(1):22-30. PubMed ID: 34112703
[TBL] [Abstract][Full Text] [Related]
8. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
Maddali MV; Churpek M; Pham T; Rezoagli E; Zhuo H; Zhao W; He J; Delucchi KL; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Laffey JG; Bellani G; Calfee CS; Sinha P;
Lancet Respir Med; 2022 Apr; 10(4):367-377. PubMed ID: 35026177
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial.
Redaelli S; von Wedel D; Fosset M; Suleiman A; Chen G; Alingrin J; Gong MN; Gajic O; Goodspeed V; Talmor D; Schaefer MS; Jung B
Intensive Care Med; 2023 Dec; 49(12):1499-1507. PubMed ID: 37906258
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study.
Slim MA; van Amstel RBE; Bos LDJ; Cremer OL; ; Wiersinga WJ; van der Poll T; van Vught LA
Crit Care; 2024 May; 28(1):151. PubMed ID: 38715131
[TBL] [Abstract][Full Text] [Related]
11. Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.
Famous KR; Delucchi K; Ware LB; Kangelaris KN; Liu KD; Thompson BT; Calfee CS;
Am J Respir Crit Care Med; 2017 Feb; 195(3):331-338. PubMed ID: 27513822
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
; Truwit JD; Bernard GR; Steingrub J; Matthay MA; Liu KD; Albertson TE; Brower RG; Shanholtz C; Rock P; Douglas IS; deBoisblanc BP; Hough CL; Hite RD; Thompson BT
N Engl J Med; 2014 Jun; 370(23):2191-200. PubMed ID: 24835849
[TBL] [Abstract][Full Text] [Related]
13. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
[No Abstract] [Full Text] [Related]
14. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
[TBL] [Abstract][Full Text] [Related]
15. Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome.
Heijnen NFL; Hagens LA; Smit MR; Cremer OL; Ong DSY; van der Poll T; van Vught LA; Scicluna BP; Schnabel RM; van der Horst ICC; Schultz MJ; Bergmans DCJJ; Bos LDJ
Am J Respir Crit Care Med; 2021 Jun; 203(12):1503-1511. PubMed ID: 33465019
[No Abstract] [Full Text] [Related]
16. Stability of ARDS subphenotypes over time in two randomised controlled trials.
Delucchi K; Famous KR; Ware LB; Parsons PE; Thompson BT; Calfee CS;
Thorax; 2018 May; 73(5):439-445. PubMed ID: 29477989
[TBL] [Abstract][Full Text] [Related]
17. Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes.
Filippini DFL; Di Gennaro E; van Amstel RBE; Beenen LFM; Grasso S; Pisani L; Bos LDJ; Smit MR
Crit Care; 2022 Nov; 26(1):363. PubMed ID: 36434629
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts.
Bos LDJ; Sjoding M; Sinha P; Bhavani SV; Lyons PG; Bewley AF; Botta M; Tsonas AM; Serpa Neto A; Schultz MJ; Dickson RP; Paulus F;
Lancet Respir Med; 2021 Dec; 9(12):1377-1386. PubMed ID: 34653374
[TBL] [Abstract][Full Text] [Related]
19. Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery.
Wiersema R; Jukarainen S; Vaara ST; Poukkanen M; Lakkisto P; Wong H; Linder A; van der Horst ICC; Pettilä V
Crit Care; 2020 Apr; 24(1):150. PubMed ID: 32295614
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
